Lee Ainslie Astrazeneca PLC Transaction History

Maverick Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1.21 Million - $1.43 Million	-22,369 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $98,396 - $107,659	-1,771 Reduced 7.34%	22,369 $1.34 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $1.46 Million - $1.82 Million	-30,189 Reduced 55.57%	24,140 $1.45 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $1.95 Million - $2.25 Million	41,309 Added 317.27%	54,329 $2.7 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $631,730 - $755,420	13,020 New	13,020 $651,000

1,340

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.